Industry Symposium 11

  
13:30-15:00    Capital Suite 14-15-16


Progressing IV iron treatment for pre-dialysis patients - NEW comparative clinical data

Chair: Andrzej Więcek, Katowice, Poland

The PROGRESS study - a randomised, controlled trial comparing iron isomaltoside 1000 (Monofer) to oral iron for iron deficiency anaemia in non-dialysis CKD
Philip Kalra, Manchester, UK
The WAVE study - a large prospective observational study of iron isomaltoside 1000 treatment for iron deficiency anaemia in CKD
Frank Leistikow, Mannheim, Germany
Optimal iron management in non-dialysis CKD - putting it all together
Saeed Ahmed, Sunderland, UK
Conclusions and questions
Andrzej Więcek, Katowice, Poland

Organised by PHARMACOSMOS


back to the timetable